On February 18, 2015, an order regarding the disclosure statement with respect to a plan of reorganization or liquidation was filed in the bankruptcy case of New England Compounding Pharmacy, Inc. and its affiliates.
The filing was assigned docket number 1137 and is described on the court’s official docket as follows:
Endorsed Order dated 2/18/2015 Re:  Motion filed by Creditor Inspira Health Network, Inc. and Inspira medical Centers, Inc. to Appear Telephonically at Hearing Scheduled for 02/24/2015 Re:  Motion filed by Creditor Committee Official Committee of Unsecured Creditors to Approve  Disclosure Statement. GRANTED. THE CLERK SHALL CONTACT ATTORNEY RAMSEY PRIOR TO THE HEARING WITH DIAL-IN INFORMATION. (cl)
New England Compounding Pharmacy, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on December 21, 2012. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Massachusetts. The case number for the lead bankruptcy case is 12-19882. The bankruptcy case is currently assigned to United States Bankruptcy Judge Henry Boroff. The law firm of Murtha Cullina LLP is acting as lead bankruptcy counsel to New England Compounding Pharmacy, Inc. in the bankruptcy case.